NAD+ questions: ageing, weight and safety
The broad claims are often the questions people actually care about. The experiments offer some useful answers, and some conspicuous blank spaces.
Does NAD+ help with weight loss?
The NMN trial in prediabetic, postmenopausal women improved muscle insulin sensitivity while leaving body composition unchanged. The cited human work does not establish weight loss from NAD+ precursors, or show that these ingredients cause weight gain.
My patience ends when muscle signalling turns into an unsupported weight claim. The physiology is interesting enough on its own, and body composition was measured in that same experiment.
Does NAD+ make skin look younger?
The review of topical nicotinamide reports reduced progression of skin ageing and hyperpigmentation, or dark colouring, in human trials. Nicotinamide is a vitamin form applied to skin in those studies.
Those findings concern a particular ingredient and route. They cannot establish that an oral NAD+ product or an infusion makes someone look younger. I give the cream research its own place in the file; transferring its result to a drip would discard the thing that was actually tested.
Is NAD+ a vitamin or a peptide?
NAD+ is a dinucleotide coenzyme. Vitamin B3 forms such as niacin and nicotinamide provide material for its synthesis; related precursors include NR and NMN. The metabolism review describes the different pathways.
Peptides are amino-acid chains. NAD+ has a different chemical structure, and the plus sign refers to its oxidised form. Its full name is nicotinamide adenine dinucleotide. The opening page follows its ordinary cellular work.
How safe is daily use?
The cited NR safety trial, six-week NR trial and single-administration NMN study generally reported good tolerability in their participants. Their duration, populations and supplied materials limit how far that reassurance reaches.
Longer-term outcomes and tissue-specific effects remain incompletely understood, as the 2025 clinical review explains. Injection quality and infusion discomfort add different concerns, discussed under IV NAD+. The dosage page records experimental amounts without selecting a personal regimen.
Patches, timing and fertility
Patches and nasal or sublingual products have little controlled support here. The cited oral and infusion experiments cannot establish the effect of those delivery methods.
The cellular NAD+ supply also follows a daily rhythm, described in the review of its metabolism. The cited trials did not establish a better morning or evening administration time. A biological rhythm supplies a hypothesis; a timing comparison would still be needed.
The human trials in this reading list did not test fertility outcomes. My answer on fertility stops at the absence of a human trial in this reading list.
Brain fog and energy accounts
Accounts of renewed energy or less brain fog are anecdotal reports, rather than clinical evidence. A person's description may be sincere while leaving the cause uncertain. Expectations, other changes and the passage of time make an uncontrolled account difficult to interpret.
The difference between feeling energetic and performing better on a specified task is the question these accounts leave with me. The human-evidence review still leaves the wider efficacy question open. Reports can suggest a question for a trial; they cannot supply its result.